RITUXIMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13082MMP | RITUXIMAB rituximab 100 mg/10 mL injection, 2 x 10 mL vials (PI, CMI) |
3 | 6 | 0 | $259.44 | $31.60 | $31.60 |
Available brands | |||||||
Riximyoa | |||||||
Truximaa |
RITUXIMAB
|
Code & Prescriber | Name, manner of administration | Max amount | No. of repeats | DPMA | Max Safety Net | General Patient Charge | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13090YMP | RITUXIMAB Injection (PI, CMI)
|
800 mg | 11 | $485.56 | $31.60 | $31.60 |
RITUXIMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13095FMP | RITUXIMAB rituximab 500 mg/50 mL injection, 50 mL vial (PI, CMI) |
2 | 2 | 1 | $458.33 | $31.60 | $31.60 |
Available brands | |||||||
Riximyoa | |||||||
Ruxiencea | |||||||
Truximaa |
RITUXIMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13096GMP | RITUXIMAB rituximab 100 mg/10 mL injection, 2 x 10 mL vials (PI, CMI) |
3 | 6 | 0 | $278.49 | $31.60 | $31.60 |
Available brands | |||||||
Riximyoa | |||||||
Truximaa |
RITUXIMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13101MMP | RITUXIMAB rituximab 500 mg/50 mL injection, 50 mL vial (PI, CMI) |
2 | 2 | 1 | $432.36 | $31.60 | $31.60 |
Available brands | |||||||
Riximyoa | |||||||
Ruxiencea | |||||||
Truximaa |
RITUXIMAB
|
Code & Prescriber | Name, manner of administration | Max amount | No. of repeats | DPMA | Max Safety Net | General Patient Charge | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13102NMP | RITUXIMAB Injection (PI, CMI)
|
800 mg | 11 | $436.03 | $31.60 | $31.60 |
- Legend
- MPMedical Practitioner